The use of biomarkers to guide precision treatment for tobacco use.

Siegel SD, Tindle HA, Bergen AW, Tyndale RF, Schnoll R

Open source

DOI
10.1016/j.addicn.2023.100076
Published
2023 Jun
Container
Addiction neuroscience
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.addicn.2023.100076,
  title = {The use of biomarkers to guide precision treatment for tobacco use.},
  author = {Siegel SD and Tindle HA and Bergen AW and Tyndale RF and Schnoll R},
  year = {2023},
  journal = {Addiction neuroscience},
  doi = {10.1016/j.addicn.2023.100076},
  url = {https://doi.org/10.1016/j.addicn.2023.100076}
}

RIS

TY  - JOUR
TI  - The use of biomarkers to guide precision treatment for tobacco use.
AU  - Siegel SD
AU  - Tindle HA
AU  - Bergen AW
AU  - Tyndale RF
AU  - Schnoll R
PY  - 2023
JO  - Addiction neuroscience
DO  - 10.1016/j.addicn.2023.100076
UR  - https://doi.org/10.1016/j.addicn.2023.100076
ER  - 

APA

SD, S., HA, T., AW, B., RF, T., & R, S. (2023). The use of biomarkers to guide precision treatment for tobacco use.. Addiction neuroscience. https://doi.org/10.1016/j.addicn.2023.100076

Source records